Growing evidence supports the hypothesis that an altered balance between pathogenic interleukin (IL)-17+ or interferon gamma (IFNγ)+ helper T (TH) cells and immunoregulatory cells with anti-inflammatory potential and the subsequent breakdown of immune tolerance may underlie the pathogenesis of autoimmune diseases, including multiple sclerosis (MS)1. This evidence concerns the gene IFNG and autoimmune disease.